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1. Introduction 
Nanomelia, a lethal recessive trait in the chick 
embryo is characterized by a severe reduction in size 
of all cartilaginous structures [ 11. It has been shown 
that the cartilage of the mutant has reduced levels of 
chondroitin sulfate [2,3] which are reflected in an 
almost complete absence of cartilage-specific proteo- 
glycan [4,5] whereas the cartilage-specific ollagen is 
unaffected by the mutation [5,6]. Ultrastructurally, 
the extracellular matrix is deficient of proteoglycan 
granules and the collagen fibrils have a normal 
morphology. The chondrocytes in the mutant cartilage 
are closer to each other than in normal cartilage [6]. 
Since it has been shown that pressure of physio- 
logical magnitude alters cyclic 3’,5’-adenosine mono- 
phosphate (CAMP) levels in epiphyseal cartilage 
[7-91 the nanomelic mutation was used to examine 
the role of the matrix in the transduction of mechan- 
ical stimuli into cellular bone remodeling signals. As 
reported here, it was found that nanomelic cartilage 
responds to pressure like normal cartilage but the 
overall CAMP content and the effect of somatomedin 
on CAMP accumulation were significantly different in 
the mutant. 
2. Materials and methods 
Tibiae were dissected from day 16 chick embryos 
and cartilage cells were isolated from the epiphyses 
by collagenase/hyaluronidase digestion as in [lo]. 
Cells were counted in a hemocytometer and viability 
ElsevierlNorth-Holland Biomedical Press 
was assessed by trypan blue extrusion. The same 
procedure was used for the isolation of cells from 
the sternum. Tibiae were exposed for 12 mm at 37°C 
to compressive forces [8] oscillating at 3 Hz [9]. 
Cells were incubated for 6 h in serum free MCDB 
culture medium in 17 X 100 mm polypropylene 
culture tubes prior to experiments. Cyclic AMP was 
measured 20 min after addition of somatomedin. 
Cellular or tissue CAMP was determined in neutralized 
10% trichloroacetic acid extracts as in [9] by radio- 
immunoassay [ 111. DNA was determined by the 
method in [12]. 
The cell culture medium was manufactured by 
Pacific Biologicals, Richmond, CA. Bacterial collagen- 
ase and hyaluronidase were purchased from Worthington 
Biochemicals, Freehold, NJ. Nanomelic embryos were 
obtained from matings between parents heterozygous 
for the mutation. Normal sibs segregating from the 
matings were used as a source of normal cartilage. 
CAMP RIA kits were obtained from New England 
Nuclear, Boston, MA. Somatomedin was prepared 
according to [13]. 
3. Results 
Table 1 shows that intermittent pressure increases 
the CAMP content (per DNA) in nanomelic chick 
tibia in the same proportion as in the normal controls. 
These experiments also revealed that the CAMP con- 
tent in nanomelia cartilage was significantly lower 
than in matched controls. 
To investigate this difference further, cells dis- 
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Table 1 
Cyclic AMP content in epiphyseal cartilage of normal and nanomehc chick 
embryos under control and pressure conditions 
Experimental Normal Nanomelic 
condition (pmol CAMP&g DNA) @ma! cAlMP/&g DNA) 
Control 6.37 1: 0.63 3.38 i 0.83 
Intermittent 
compression 10.56 i: I,40 5.52 * 1.36 
Chick embryo tibiae were dissected and exposed for 12 min at 37°C in vitro to 
intermittent comprcssjon,and cAMP content was measured as in section 2. 
Results arc the mean + SEM of 15 sampfes each 
persed by collage .ase/hyaluronidase digestion from 
tibiae and sterna were incubated under culture con- 
ditions in the presence and absence of somatomedin, 
a hormone reported to stir&ate cartilage CAMP 
accumulation f 141. As seen in table 2 the cAMP con- 
tent of dispersed nanomelic sternal cells in culture 
was significantly lower than that of matched control. 
Moreover, substantial differences were observed in 
CAMP response to somatomedin, a serum factor 
known to affect proteog~ycan sulfation. ~omatorn~d~ 
strongly stimulated CAMP accumulation in nanomelic 
cells and had no effect on matched controls under 
the same conditions. Figure 1 shows a dose-response 
curve for the effect of somatomedin on CAMP 
accumulation in nanomelic and control sternal ceils. 
An appro~~ately linear log dose-response relation- 
ship was observed between 8 and 4000 r&ml. 
4. Discussion 
The present results indicate that nanomelic cartilage 
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Fig.1 . Dose-response curve ~~~ma~~rnedi~ an CAMP BCCU- 
muWon in nanomelie (o-o) and normal (a-5) sternal c&s 
Cells were isoiated, incubated with somatomedin and CAMP 
was measured as in section 2 on duplicate samples. The 
broken lines represent he actual values and the solid line, 
a regression analysis. 
The effect of somatomedin and ins&n on cAMP accumulation in narmal and 
nanomelic sternal chick cartilage cells 
Normal Nanomelic 
(pmol cAMP/106 cc&) (pmol cAMP/106 cells) 
COIltrOl 2.50 + 0.28 1.14 f 0.x3 
Somatom~d~ (4 fig/mQ 2.68 * 0.34 12.20 12.54 
Control 1.83 + 0.45 0.95 f 0.28 
Insulin (2 &ml) 1.68 + 0.35 0.74 * 0.23 
Cells were kolateci, ncubated, exposed to hormones, and cAMP was measured as 
in section 2. Somatomed~ results are the mean z S&i of 6 samples from 2 
independent experiments. Insulin results are mean * SEM of 6 samples from 
3 experiments 
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responds to intermittent pressure by increasing its 
CAMP levels in the same proportion as normal 
cartilage. Since this mutant cartilage lacks cartilage 
specific proteogiycan, these results suggest hat this 
matrix component may not play an important role in 
the transduction of mechanical stimuli into cellular 
bone remodeling signals. Of particular interest was 
the finding that chondrocytes from nanomelic chick 
embryos had lower steady state levels of CAMP which 
could rise substantially in response to somatomedin. 
Cyclic AMP has been implicated in the past in the 
action of somatomedin as well as in proteoglycan 
synthesis and in chondrogenesis. Those findings, 
however, are derived from various systems and do not 
fit into a coherent picture. Positive effects of CAMP 
on chondrogenesis were found in [ 161 where 
butyrylate CAMP and theophylline stimulated macro- 
molecular synthesis in the pelvic cartilage of day 
lo- 12 chick embryos. Growth hormone-dependent 
serum factors also increased CAMP levels in this tissue 
[ 171. Cyclic AMP analogues enhanced sulfate 
incorporation into matrix proteoglycans of fetal rat 
chondrocytes [ 151. However somatomedin was found 
to reduce the activity of cartilage adenylate cyclase 
[ 181 and in rabbit articular chondrocytes dibutyryl 
CAMP to promote the synthesis of type 1 collagen 
[ 191, characteristic of the fibroblast phenotype 
rather than the cartilage one. Dibutyryl CAMP added 
to cloned rat cell myoblast cultures caused morpho- 
logical changes suggestive of chondrogenesis but at 
the biochemical level promoted the synthesis of type 1 
collagen [20]. Similarly, in chick embryo somites 
CAMP analogues inhibited sulfated glycosaminoglycan 
accumulation [2 11, an expression of chondrogenesis. 
However, in limb bud cell cultures CAMP derivatives 
stimulate chondrogenesis [22]. 
These observations do not explain the differences 
between the reported findings but they throw new 
light on the effect of the nanomelic mutation and 
lend support to the hypothesis that CAMP is involved 
in the regulation of development and in the control 
of proteoglycan synthesis. It is suggested that the 
incomplete expression of the cartilage phenotype in 
nanomelic embryos may be related to the reduced 
levels of CAMP in the mutant chondrocytes and to 
their abnormal response to somatomedin. These 
preliminary findings are reported since it appears 
that the nanomelic mutant can serve as a powerful 
experimental tool for: 
(i) Studying the complex relationship between 
somatomedin CAMP and cartilage differentiation; 
(ii) Somatomedin receptor investigations; 
(iii) Developing an expedient sensitive bioassay for 
somatomedin. 
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